PMC:7048180 / 9869-10162 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T38","span":{"begin":167,"end":174},"obj":"Body_part"}],"attributes":[{"id":"A38","pred":"fma_id","subj":"T38","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"Some of the most potent SARS-CoV-specific neutralizing antibodies (e.g. m396, CR3014) that target the receptor binding site of SARS-CoV failed to bind 2019-nCoV spike protein, indicating that it is necessary to develop novel monoclonal antibodies that could bind specifically to 2019-nCoV RBD."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T48","span":{"begin":24,"end":32},"obj":"Disease"},{"id":"T49","span":{"begin":127,"end":135},"obj":"Disease"}],"attributes":[{"id":"A48","pred":"mondo_id","subj":"T48","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A49","pred":"mondo_id","subj":"T49","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Some of the most potent SARS-CoV-specific neutralizing antibodies (e.g. m396, CR3014) that target the receptor binding site of SARS-CoV failed to bind 2019-nCoV spike protein, indicating that it is necessary to develop novel monoclonal antibodies that could bind specifically to 2019-nCoV RBD."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T51","span":{"begin":167,"end":174},"obj":"Chemical"}],"attributes":[{"id":"A51","pred":"chebi_id","subj":"T51","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"Some of the most potent SARS-CoV-specific neutralizing antibodies (e.g. m396, CR3014) that target the receptor binding site of SARS-CoV failed to bind 2019-nCoV spike protein, indicating that it is necessary to develop novel monoclonal antibodies that could bind specifically to 2019-nCoV RBD."}

{"project":"LitCovid-sentences","denotations":[{"id":"T61","span":{"begin":0,"end":293},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Some of the most potent SARS-CoV-specific neutralizing antibodies (e.g. m396, CR3014) that target the receptor binding site of SARS-CoV failed to bind 2019-nCoV spike protein, indicating that it is necessary to develop novel monoclonal antibodies that could bind specifically to 2019-nCoV RBD."}

{"project":"LitCovid-PubTator","denotations":[{"id":"360","span":{"begin":24,"end":32},"obj":"Species"},{"id":"361","span":{"begin":127,"end":135},"obj":"Species"},{"id":"362","span":{"begin":151,"end":160},"obj":"Species"},{"id":"363","span":{"begin":279,"end":288},"obj":"Species"}],"attributes":[{"id":"A360","pred":"tao:has_database_id","subj":"360","obj":"Tax:694009"},{"id":"A361","pred":"tao:has_database_id","subj":"361","obj":"Tax:694009"},{"id":"A362","pred":"tao:has_database_id","subj":"362","obj":"Tax:2697049"},{"id":"A363","pred":"tao:has_database_id","subj":"363","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Some of the most potent SARS-CoV-specific neutralizing antibodies (e.g. m396, CR3014) that target the receptor binding site of SARS-CoV failed to bind 2019-nCoV spike protein, indicating that it is necessary to develop novel monoclonal antibodies that could bind specifically to 2019-nCoV RBD."}